Topical Administration of Mometasone Is Not Helpful in Post-COVID-19 Olfactory Dysfunction

Persistent olfactory dysfunction is a major concern post-COVID-19, affecting up to 5% of all patients. Different therapeutic options, including mometasone nasal spray, have been recommended, only some of which have been validated for post-COVID-19 olfactory dysfunction. In this study we psychophysic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hintschich, Constantin A., Dietz, Melanie, Haehner, Antje, Hummel, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605508/
https://www.ncbi.nlm.nih.gov/pubmed/36294918
http://dx.doi.org/10.3390/life12101483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605508/
https://www.ncbi.nlm.nih.gov/pubmed/36294918
http://dx.doi.org/10.3390/life12101483

Ejemplares similares